课题基金 / 基金详情

IMMUNIZATION STRATEGY WITH ALVAC-HIV VCP1452 IN HIV-1 SUBJECTS

IMMUNIZATION STRATEGY WITH ALVAC-HIV VCP1452 IN HIV-1 SUBJECTS
HIV-1 受试者中 ALVAC-HIV VCP1452 的免疫策略
批准号:
7377418
负责人:
Joseph J Eron
金额:
$2.01万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-12-01 至 2006-11-30

项目摘要

项目成果

Joseph J Eron的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this research study is to see if either stopping anti-HIV drugs for short periods of time or adding a vaccine to the anti-HIV drugs already being taken will help to better control HIV infection. The study will check to see if the vaccine is safe to use in people with HIV infection. The study will also check to see if stopping anti-HIV medicines for short periods of time is safe.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HIV/AIDS Clinical Trials Unit (CTU) COVID-19 Admin Supplement
University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit
Clinical Core
Clinical Core
国内基金
海外基金
基于Trojan Horse strategy的新型药物递呈系统在肝癌射频消融中的应用
  • 批准号:
    LQ19H160021
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2018
  • 负责人:
    唐科忠
  • 依托单位:
Strategy I植物的铁元素吸收代谢分子调控机制研究